
ARS Pharmaceuticals, Inc.
SPRYNasdaqCIK 1671858HealthcareFiscal year ends Dec 31
Reports and events: 122 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2616:02 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0000950170-24-049071 |
| 2024-03-2916:14 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-041150 |
| 2024-03-2116:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034689 |
| 2024-03-2116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034678 |
| 2024-03-0712:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-061842 |
| 2023-11-0916:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061996 |
| 2023-11-0916:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061989 |
| 2023-09-2516:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-103530 |
| 2023-09-2516:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-241345 |
| 2023-09-2006:05 ET | 8-K | 8.01 Other events | 0001193125-23-237996 |
| 2023-09-0116:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-227662 |
| 2023-08-3117:25 ET | SC 13D | Ownership report, active investor | 0001104659-23-097323 |
| 2023-08-1016:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041310 |
| 2023-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041294 |
| 2023-06-2816:32 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-177543 |
| 2023-05-1616:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-146147 |
| 2023-05-1509:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021997 |
| 2023-05-1509:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021996 |
| 2023-05-0909:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-139053 |
| 2023-05-0116:30 ET | DEF 14A | Proxy statementPeriod 2023-06-27 | 0001193125-23-130534 |
| 2023-03-2316:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009491 |
| 2023-03-2316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-009485 |
| 2023-03-1309:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-068584 |
| 2023-02-2216:11 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-23-044823 |
| 2023-02-1406:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-036914 |
| 2023-01-1717:06 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-23-009540 |
| 2022-12-0917:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-301873 |
| 2022-12-0617:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-299482 |
| 2022-11-3016:23 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-22-001216 |
| 2022-11-2116:07 ET | SC 13D | Ownership report, active investor | 0001193125-22-289924 |
| 2022-11-1817:06 ET | SC 13D | Ownership report, active investor | 0001193805-22-001578 |
| 2022-11-1814:17 ET | SC 13D | Ownership report, active investor | 0001193125-22-288763 |
| 2022-11-1814:09 ET | SC 13D | Ownership report, active investor | 0001193125-22-288750 |
| 2022-11-1813:58 ET | SC 13D | Ownership report, active investor | 0001193125-22-288740 |
| 2022-11-0816:51 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-280241 |
| 2022-11-0216:10 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021234 |
| 2022-11-0206:07 ET | 8-K | 8.01 Other events | 0001193125-22-275336 |
| 2022-10-2716:06 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-270962 |
| 2022-10-2107:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-266351 |
| 2022-09-3016:07 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-255494 |
| 2022-09-0216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-237900 |
| 2022-08-1116:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016840 |
| 2022-07-2117:01 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-199246 |
| 2022-06-1316:32 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-172958 |
| 2022-05-1216:26 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009694 |
| 2022-05-1216:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-148646 |
| 2022-05-0616:06 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-22-143631 |
| 2022-04-2816:52 ET | DEF 14A | Proxy statementPeriod 2022-06-10 | 0001193125-22-127830 |
| 2022-03-3116:11 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-005202 |
| 2022-03-3116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-091747 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 04:18 ET. Listed shows no prices and gives no investment advice.